menu ☰
menu ˟

Expression of CD25 antigen on CD34+ cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine

28 Feb 2014

Expression of CD25 antigen on CD34+ cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine

Blood Cancer Journal 4,
e187 (February 2014). doi:10.1038/bcj.2014.9

Authors: P Miltiades, E Lamprianidou, T P Vassilakopoulos, S G Papageorgiou, A G Galanopoulos, S Vakalopoulou, V Garypidou, M Papaioannou, E Hadjiharissi, V Pappa, H A Papadaki, E Spanoudakis, K Tsatalas & I Kotsianidis

Date: 
28 February 2014

Click here to view the full article which appeared in Blood Cancer Journal

IPH Logo